Fastlane Launches AI Marketing Platform That Researches, Creates and Runs Campaigns End to End Atom Finance Launches Embedded Stock and Crypto Intelligence Tech for Trading Platforms
Commits to partnering with fintechs, neobanks, and brokers to transform the retail investing experience NEW…
Hidoc Dr., the Fastest Growing Medical Platform Used by 800K Doctors Globally, is now available in North America
WILMINGTON, Del.–(BUSINESS WIRE)–Hidoc Dr., the number one doctor networking and medical learning platform in India,…
Cognira Recognized As One Of The Fastest-Growing Companies For The Third Year In A Row
Cognira has been recognized as one of the fastest-growing companies in 2022. Visit ft.com to…
Reunited: $1 Billion Independent Firm, Ascent Wealth Partners, Rejoins Dynasty Financial Partners Network
Upstate New York Firm with Three Locations Rejoins the Dynasty Financial Partners Network ST. PETERSBURG,…
Kim Sanchez from Abnormal Security Named on CRN’s 2022 Women of the Channel List
SAN FRANCISCO–(BUSINESS WIRE)–Abnormal Security, the leading AI-based cloud-native email security platform, today announced that CRN®,…
Dialpad Channel Leaders Ally Murtlow, Kaitlin Boughton, and Dani Pickens named to CRN’s 2022 Women of the Channel List
Three exceptional channel leaders celebrated by CRN for their impact on the industry SAN FRANCISCO–(BUSINESS…
Tsunami Secures Majority Investment from Point72 Hyperscale
MENLO PARK, Calif.–(BUSINESS WIRE)–Point72 Hyperscale, the private equity strategy that uses applied artificial intelligence to…
Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research
Takes an Important Step Towards the Start of its Clinical Trial to Evaluate the Analytical…
Outlook Therapeutics to Participate at the Virtual Investor 2022 CEO Spotlight
Live moderated video webcast on Wednesday, May 11th at 1:00 PM ET ISELIN, N.J., May…
Celsion Corporation to Hold First Quarter 2022 Financial Results and Business Update Conference Call on Monday, May 16, 2022
LAWRENCEVILLE, N.J., May 09, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company…
Allogene Therapeutics Named 2022 Bay Area “Best Place to Work” by San Francisco Business Times and Silicon Valley Business Journal
Allogeneic CAR T Pioneer Highest Ranked Bay Area Biotech in the Large Company Category Based on…
Longeveron to Announce First Quarter 2022 Financial Results on May 13, 2022
Live conference call at 8:30 a.m. EST MIAMI, May 09, 2022 (GLOBE NEWSWIRE) — Longeveron…
Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results
SOUTH SAN FRANCISCO, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
Albireo to Report Q1 2022 Financial Results on May 16
Conference call and webcast to be held at 4:30 pm ET BOSTON, May 09, 2022…
Acer Therapeutics Announces Agreement with FDA on Special Protocol Assessment for its Phase 3 EDSIVO™ (celiprolol) Trial in Vascular Ehlers-Danlos Syndrome Patients
Phase 3 DiSCOVER clinical trial initiation expected by end of Q2 2022 NEWTON, Mass., May…
Dyadic Announces Successful Toxicology Data Published in “Toxicologic Pathology”
Toxicology data published in the international peer-reviewed scientific journal “Toxicologic Pathology” demonstrates excellent safety profile…
Finch Therapeutics to Host Corporate Update Conference Call and Webcast on May 16, 2022
SOMERVILLE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
Spero Therapeutics to Provide Business Update and Report First Quarter 2022 Financial Results on Monday, May 16, 2022
CAMBRIDGE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that…
Mainz Biomed to Host Key Opinion Leader Event at DDW 2022
Digestive Disease Week is the largest international gathering of physicians, researchers and academics in the…
Impel Pharmaceuticals to Report First Quarter 2022 Financial Results on Monday, May 16, 2022
SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) — Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company…